Exane Derivatives’s BCE BCE Stock Holding History

Exane Derivatives’s Portfolio BCE Stock Details BCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,050	Closed	-$9.9K	–	672
2018 Q4	$9.9K	Hold	2,050	–	–	﹤0.01%	465
2018 Q3	$156	Hold	2,050	–	–	﹤0.01%	605
2018 Q2	$2.38K	Buy	2,050 +1,000	+95%	+$42K	﹤0.01%	486
2018 Q1	$19.3K	Sell	1,050 -3,600	-77%	-$162K	﹤0.01%	395
2017 Q4	$117K	Hold	4,650	–	–	0.02%	279
2017 Q3	$106K	Hold	4,650	–	–	0.02%	248
2017 Q2	$154K	Sell	4,650 -200	-4%	-$9.02K	0.03%	220
2017 Q1	$341K	Sell	4,850 -3,900	-45%	-$172K	0.08%	158
2016 Q4	$486K	Buy	8,750 +750	+9%	+$33.1K	0.1%	156
2016 Q3	$837K	Buy	+8,000	New	+$379K	0.13%	104
2016 Q2	–	Sell	-7,350	Closed	-$2.17M	–	558
2016 Q1	$2.17M	Hold	7,350	–	–	0.29%	57
2015 Q4	$896K	Sell	7,350 -2,140	-23%	-$90.2K	0.12%	85
2015 Q3	$2.19M	Buy	9,490 +2,000	+27%	+$82.1K	0.28%	64
2015 Q2	$1.55M	Buy	7,490 +935	+14%	+$41.1K	0.17%	71
2015 Q1	$1.89M	Buy	6,555 +1,600	+32%	+$71.3K	0.21%	65
2014 Q4	$1.97M	Buy	+4,955	New	+$222K	0.27%	67

Other funds holding BCE

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Exane Derivatives's BCE Position: Q2 2022 in Review

Exane Derivatives sold out of BCE (BCE) in Q2 2022, closing a stake of 20,084 shares — an estimated $1.11M sold.

Exane Derivatives first reported a position in BCE in Q4 2015 and held it in 18 quarters. The position peaked at $7.54M in Q1 2019. 600 funds tracked by Wall St. Rank hold BCE as of Q2 2022.

Exane Derivatives reported no remaining BCE position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 20,084 BCE shares in Q2 2022, an estimated $1.11M.
Exane Derivatives first reported a position in BCE in Q4 2015 and held it in 18 quarters.
Exane Derivatives's BCE position peaked at $7.54M in Q1 2019.
600 funds tracked by Wall St. Rank held BCE as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.